Skip to main content
EnglishEnglish
EnglishEnglishArabicArabicChinese (Simplified)Chinese (Simplified)FrenchFrenchGermanGermanHindiHindiPortuguesePortugueseRussianRussianSpanishSpanishSwahiliSwahili

Header

  • Contact us
  • Subscribe to newsletter
Home The Task Force for Global Health logo
  • https://twitter.com/GlobalHep
  • https://www.facebook.com/GlobalHep/
  • https://www.linkedin.com/company/coalition-for-global-hepatitis-elimination
Donate
Add a Program
Add a Program
Profile
Logout

Main navigation

  • About
    • Who we are
    • What we do
    • Our team
    • Technical Advisory Board
    • Executive Board
    • Donor Acknowledgements
    • CGHE Annual Reports
      • Annual Report 2022
      • Annual Report 2021
      • Annual Report 2020
    • CGHE Publications
  • Partner programs
    • Programs search
  • Data dashboards
    • Country data dashboards
    • National Hepatitis Elimination Profiles
  • Evidence base
    • All evidence (search)
      • Evidence Base Methodology
    • HCV Treatment in Pregnancy
      • Tip-HepC Registry
      • TiP-HepC Systematic Review Results
    • Action Plan Systematic Review
    • Hepatitis B Birth Dose Vaccine Systematic Review
      • Synthesis Brief of Hepatitis B Birth Dose Evidence Base
    • HCV Testing Systematic Review
    • COVID-19 Evidence Hub
      • COVID-19 and Liver Disease Synthesis
      • Clinical Liver Disease COVID-19 special series
        • The COVID-19 Pandemic: An Epidemiologic, Public Health, and Clinical Brief
        • Synthesis of Liver Associations Recommendations for Hepatology and Liver Transplant Care During the COVID-19 Pandemic
    • Innovations in Hepatitis Elimination (CLD Series)
      • Author Interviews
      • Introduction to Series
      • Past Publications
      • Author Guidance
    • Hepatitis Elimination Help Desk
  • Resources
    • Hep C Elimination Tool
      • Access the Tool
      • User Guide
      • Frequently Asked Questions
    • Search resources
    • Technical Assistance Help Desk and Frequently Asked Questions
    • Toolkit: Birth Dose Vaccination in Africa
  • Elimination champions
    • Nominations for Elimination Champions
  • Webinars & Events
    • Hep Test
    • Linkage to care
    • Strategic Information Collaborative
    • Regional Hepatitis Elimination
    • HepB Birth Dose Introduction in AFRO
    • Innovations in Hepatitis Elimination
    • NIH "Moving from Hepatitis Discovery to Elimination"
    • Search webinars
    • Treatment of HCV in Pregnancy for Hepatitis (TiP-HepC)
      • Webinar 1: Challenges
      • Webinar 2: Strategies
  • News
    • Announcements
    • Blog
    • Elimination Champions
    • Events
    • Newsletters
    • Press releases
    • Publications
    • News search
  • UN Group of Friends
  1. Home
  2. Evidence base
  3. Evidence base search

Evidence base articles search

The evidence base was developed using rigorous review methods for the identification and quality assessment of eligible systematic reviews and guideline and policy documents. In response to identified global research priorities, the evidence base currently presents characteristics of interventions to inform implementation of hepatitis B birth dose , HCV testing and hepatitis B and C action plans. Updates to the evidence base are planned to address subsequent priorities.

Edit

Evidence base search

Filter

  • (-) HCV testing
  • Hepatitis B
  • Hepatitis C
  • Coinfection with HIV
  • HBV testing and linkage to care
  • HCV testing and linkage to Care
  • Linkage to care
  • Persons who inject drugs: Medication assisted therapy
  • Screening and diagnosis
  • Testing
  • Treatment
  • Adolescents (10 - 19 years of age)
  • Adults
  • Adults (> 19 years of age)
  • All ages
  • Birth cohorts of adults
  • Blood transfusion recipients
  • Dialysis patients
  • General Population
  • Immigrants/Refugees
  • Incarcerated populations (current and former)
  • Individuals with blood disorders
  • Men who have sex with men
  • People experiencing homelessness
  • Persons who inject drugs
  • Persons with substance use disorder
  • Pregnant women
  • Young Adults <21
  • Cross-sectional
  • Prospective cohort
  • Randomized control trial
  • Retrospective cohort
  • Australia
  • Belgium
  • Brazil
  • Cambodia
  • Cameroon
  • Canada
  • Chad
  • China
  • Egypt
  • France
  • Georgia
  • Germany
  • Hong Kong
  • India
  • Iran (Islamic Republic of)
  • Ireland
  • Italy
  • Japan
  • Kenya
  • Korea (Republic of)
  • Malaysia
  • Netherlands
  • Norway
  • Pakistan
  • Poland
  • Portugal
  • Russian Federation
  • Serbia
  • Spain
  • Sri Lanka
  • Sweden
  • Switzerland
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States of America
  • Viet Nam
  • Laboratory-based antibody test
  • Laboratory-based antibody test,Laboratory-based HCV core antigen (cAg) confirmatory test
  • Laboratory-based antibody test,Laboratory-based PCR/RNA (confirmatory) test
  • Laboratory-based antibody test, Point-of-care PCR/RNA test
  • Laboratory-based HCV core antigen (cAg) confirmatory test
  • Laboratory-based PCR/RNA (confirmatory) test
  • Point-of-care antibody test (rapid test)
  • Point-of-care antibody test (rapid test), Laboratory-based PCR/RNA (confirmatory) test
  • Point-of-care antibody test (rapid test), Point-of-care PCR/RNA test
  • Point-of-care antibody test (rapid test), Laboratory-based HCV core antigen (cAg) confirmatory test
  • Point-of-care PCR/RNA test
Displaying 1 - 12 of 163
  • Hepatitis C Virus Infection in the Dallas County Jail: Implications for Screening, Prevention, and Linkage to Care

    2019
    Public Health Reports

    134

    626-633
  • A Co-localized Hepatitis C Virus Clinic in a Primary Care Practice Improves Linkage to Care in a High Prevalence Population

    2020
    The American Journal of Medicine

    133

    705-712
  • Hepatitis virus (HCV) diagnosis and access to treatment in a UK cohort

    2018
    BMC Infectious Diseases

    18

  • Implementation of baby boomer hepatitis C screening and linking to care in gastroenterology practices: a multi-center pilot study

    2016
    BMC Gastroenterology

    16

    45
  • Eighteen- to 30-year-olds more likely to link to hepatitis C virus care: An opportunity to decrease transmission

    2016
    Journal of Viral Hepatitis

    23

    274-281
  • Targeted hepatitis C screening among ex-injection drug users in the community

    2014
    Journal of Gastroenterology and Hepatology (Australia)

    29

    116-120
  • Change in treatment paradigm in people who previously injected drugs with chronic hepatitis C in the era of direct-acting antiviral therapy

    2019
    Journal of Gastroenterology and Hepatology (Australia)

    34

    1641-1647
  • Prevalence of elevated ALT values, HBsAg, and anti-HCV in the primary care setting and evaluation of guideline defined hepatitis risk scenarios

    2015
    Journal of Hepatology

    62

    12561264
  • Is there a benefit for health care workers in testing HIV, HCV and HBV in routine before elective arthroplasty?

    2016
    Orthopaedics and Traumatology: Surgery and Research

    102

    513-516
  • Point-of-care hepatitis C testing from needle and syringe programs: An Australian feasibility study

    2019
    International Journal of Drug Policy

    72

    91-98
  • Awareness of biologically confirmed HCV among a community residing sample of drug users in Baltimore City

    2014
    Journal of Community Health

    39

  • Results of a Rapid Hepatitis C Virus Screening and Diagnostic Testing Program in an Urban Emergency Department

    2016
    Annals of Emergency Medicine

    67

    119-128

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page ››
  • Last page Last »

Contact us

globalhep [at] taskforce.org

Tel: +1-404-371-0466

 

Photos on home page by Tayvessa Wilson, Conor Ashleigh, and Zunaid Murshed Paiker

Support us

Donate

Follow us

  • https://twitter.com/GlobalHep
  • https://www.facebook.com/GlobalHep/
  • https://www.linkedin.com/company/coalition-for-global-hepatitis-elimination

Sign up to our newsletter

<

Footer

  • Contact
© 2019 - 2023 Coalition for Global Hepatitis Elimination
Website by Manta Ray Media
q